VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q100306747 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010630.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q100306747‏
024 ‎‡a 0000-0002-1065-7028‏ ‎‡2 orcid‏
024 ‎‡a 57194858780‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q100306747‏
100 0 ‎‡a María Valero de Vicente‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a María Valero de Vicente‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A Phase 2 Study of Preoperative Capecitabine and Concomitant Radiation in Women With Advanced Breast Cancer‏
670 ‎‡a Author's Adjuvant trastuzumab in HER2-positive breast cancer‏
670 ‎‡a Author's Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients‏
670 ‎‡a Author's Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials‏
670 ‎‡a Author's Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.‏
670 ‎‡a Author's Genomic grade index is associated with response to chemotherapy in patients with breast cancer‏
670 ‎‡a Author's Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment‏
670 ‎‡a Author's Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis‏
670 ‎‡a Author's Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index‏
670 ‎‡a Author's Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active th‏
670 ‎‡a Author's Primary angiosarcomas of the breast‏
670 ‎‡a Author's Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy‏
670 ‎‡a Author's Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management‏
670 ‎‡a Author's Risk factors for falls in older patients with cancer.‏
670 ‎‡a Author's Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment.‏
670 ‎‡a Author's Universal Family Drug Prevention Programs. A Systematic Review‏
909 ‎‡a (orcid) 0000000210657028‏ ‎‡9 1‏
909 ‎‡a (scopus) 57194858780‏ ‎‡9 1‏
919 ‎‡a assessmentofanrnainterferencescreenderivedmitoticandceramidepathwaymetageneasapredictorofresponsetoneoadjuvantpaclitaxelforprimarytriplenegativebreastcanceraretrospectiveanalysisof5clinicaltrials‏ ‎‡A Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials‏ ‎‡9 1‏
919 ‎‡a circulatingtumorcellphenotypepredictsrecurrenceandsurvivalinpancreaticadenocarcinoma‏ ‎‡A Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.‏ ‎‡9 1‏
919 ‎‡a locoregionalrecurrenceriskforpatientswitht12breastcancerwith13positivelymphnodestreatedwithmastectomyandsystemictreatment‏ ‎‡A Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment‏ ‎‡9 1‏
919 ‎‡a genomicgradeindexisassociatedwithresponsetochemotherapyinpatientswithbreastcancer‏ ‎‡A Genomic grade index is associated with response to chemotherapy in patients with breast cancer‏ ‎‡9 1‏
919 ‎‡a universalfamilydrugpreventionprogramsasystematicreview‏ ‎‡A Universal Family Drug Prevention Programs. A Systematic Review‏ ‎‡9 1‏
919 ‎‡a roleofultrasonographyofregionalnodalbasinsinstagingtriplenegativebreastcancerandimplicationsforlocalregionaltreatment‏ ‎‡A Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment.‏ ‎‡9 1‏
919 ‎‡a riskfactorsforfallsinolderpatientswithcancer‏ ‎‡A Risk factors for falls in older patients with cancer.‏ ‎‡9 1‏
919 ‎‡a reliabledetectionofsomaticmutationsinfineneedleaspiratesofpancreaticcancerwithnextgenerationsequencingimplicationsforsurgicalmanagement‏ ‎‡A Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management‏ ‎‡9 1‏
919 ‎‡a prognosisforpatientswithmetastaticbreastcancerwhoachieveanoevidenceofdiseasestatusaftersystemicorlocaltherapy‏ ‎‡A Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy‏ ‎‡9 1‏
919 ‎‡a primaryangiosarcomasofthebreast‏ ‎‡A Primary angiosarcomas of the breast‏ ‎‡9 1‏
919 ‎‡a multicenterphase3randomizedtrialcomparingdocetaxelandtrastuzumabwithdocetaxelcarboplatinandtrastuzumabas1linechemotherapyforpatientswithher2geneamplifiedmetastaticbreastcancerbcirg007study2highlyactiveth‏ ‎‡A Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active th‏ ‎‡9 1‏
919 ‎‡a malnutritioninolderpatientswithcancerappraisalofthemininutritionalassessmentweightlossandbodymassindex‏ ‎‡A Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index‏ ‎‡9 1‏
919 ‎‡a locoregionaltreatmentoutcomesforbreastcancerpatientswithipsilateralsupraclavicularmetastasesatdiagnosis‏ ‎‡A Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis‏ ‎‡9 1‏
919 ‎‡a phase2studyofpreoperativecapecitabineandconcomitantradiationinwomenwithadvancedbreastcancer‏ ‎‡A A Phase 2 Study of Preoperative Capecitabine and Concomitant Radiation in Women With Advanced Breast Cancer‏ ‎‡9 1‏
919 ‎‡a adjuvanttrastuzumabinher2positivebreastcancer‏ ‎‡A Adjuvant trastuzumab in HER2-positive breast cancer‏ ‎‡9 1‏
919 ‎‡a analysisoffcγreceptoriiiaandiiapolymorphismslackofcorrelationwithoutcomeintrastuzumabtreatedbreastcancerpatients‏ ‎‡A Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients‏ ‎‡9 1‏
996 ‎‡2 CAOONL|ncf13776791‏
996 ‎‡2 BNE|XX1641461‏
996 ‎‡2 ISNI|0000000059678650‏
996 ‎‡2 BNF|16710898‏
996 ‎‡2 NLA|000046292753‏
996 ‎‡2 BNE|XX1105825‏
996 ‎‡2 BNE|XX1458896‏
996 ‎‡2 PTBNP|1817270‏
996 ‎‡2 ISNI|0000000083883849‏
996 ‎‡2 ISNI|0000000367665931‏
996 ‎‡2 ISNI|000000006840060X‏
996 ‎‡2 NUKAT|nx2022554744‏
996 ‎‡2 BNE|XX1151317‏
996 ‎‡2 BNE|XX1083532‏
996 ‎‡2 BNE|XX1179186‏
996 ‎‡2 BNE|XX1298097‏
996 ‎‡2 RERO|A027483645‏
996 ‎‡2 SUDOC|184749719‏
996 ‎‡2 PTBNP|971361‏
996 ‎‡2 ISNI|0000000120202038‏
996 ‎‡2 BNE|XX1481818‏
996 ‎‡2 SUDOC|234246138‏
996 ‎‡2 PTBNP|1603792‏
996 ‎‡2 ISNI|0000000059359430‏
996 ‎‡2 LC|no2017129485‏
996 ‎‡2 BNE|XX1054171‏
996 ‎‡2 LC|n 95922939‏
996 ‎‡2 DNB|140527362‏
996 ‎‡2 ISNI|0000000069384883‏
996 ‎‡2 LC|no2008167921‏
996 ‎‡2 BNC|981058515341706706‏
996 ‎‡2 BNE|XX1798586‏
996 ‎‡2 ISNI|0000000409975162‏
996 ‎‡2 DNB|1157407269‏
996 ‎‡2 BNCHL|10000000000000000027324‏
996 ‎‡2 DNB|1156969786‏
996 ‎‡2 DNB|1157264042‏
996 ‎‡2 PTBNP|53998‏
996 ‎‡2 BNE|XX1122815‏
996 ‎‡2 DNB|1151729124‏
996 ‎‡2 W2Z|1606126540814‏
996 ‎‡2 BNE|XX6054101‏
996 ‎‡2 LC|no2011098097‏
996 ‎‡2 SUDOC|066890225‏
996 ‎‡2 BNC|981058516060106706‏
996 ‎‡2 ISNI|0000000068620848‏
996 ‎‡2 BLBNB|000208090‏
996 ‎‡2 BIBSYS|97048826‏
996 ‎‡2 NKC|jo20231195762‏
996 ‎‡2 LC|nr2004016032‏
996 ‎‡2 J9U|987007429853905171‏
996 ‎‡2 ISNI|0000000034608568‏
996 ‎‡2 BNE|XX1046909‏
996 ‎‡2 ISNI|0000000061097265‏
996 ‎‡2 PTBNP|150303‏
996 ‎‡2 DNB|1056726989‏
996 ‎‡2 BNE|XX1151305‏
996 ‎‡2 ISNI|0000000358850166‏
996 ‎‡2 BNE|XX969144‏
996 ‎‡2 BNC|981058612464506706‏
996 ‎‡2 BNE|XX1717690‏
996 ‎‡2 BNE|XX1118669‏
996 ‎‡2 SUDOC|159007488‏
996 ‎‡2 DNB|1185584781‏
996 ‎‡2 ISNI|0000000071000842‏
996 ‎‡2 LC|n 2006218148‏
996 ‎‡2 BNE|XX1212962‏
996 ‎‡2 BNE|XX4743013‏
996 ‎‡2 ISNI|0000000060194514‏
996 ‎‡2 DNB|1067107665‏
996 ‎‡2 LC|n 98096226‏
996 ‎‡2 DNB|105766782X‏
996 ‎‡2 LC|no2005082497‏
996 ‎‡2 ISNI|0000000052945437‏
996 ‎‡2 BNE|XX881863‏
996 ‎‡2 DNB|133005704‏
996 ‎‡2 BNE|XX893437‏
996 ‎‡2 BNE|XX6166982‏
996 ‎‡2 BNE|XX1115500‏
996 ‎‡2 LC|n 79012071‏
996 ‎‡2 LC|no2017014591‏
996 ‎‡2 LC|n 85248116‏
996 ‎‡2 ISNI|0000000068294704‏
996 ‎‡2 BNF|16199581‏
996 ‎‡2 ISNI|0000000078241462‏
996 ‎‡2 BNE|XX1583961‏
996 ‎‡2 LC|n 98073916‏
996 ‎‡2 BNE|XX1003712‏
996 ‎‡2 BNC|981061181668506706‏
996 ‎‡2 ISNI|0000000060204890‏
996 ‎‡2 PTBNP|225862‏
996 ‎‡2 ISNI|0000000070799031‏
996 ‎‡2 BNF|14576504‏
996 ‎‡2 LC|nr 94021338‏
996 ‎‡2 ISNI|0000000078032855‏
996 ‎‡2 BNF|12266150‏
996 ‎‡2 LC|n 82061234‏
996 ‎‡2 DNB|133532528X‏
996 ‎‡2 NUKAT|n 2007141443‏
996 ‎‡2 ARBABN|000064562‏
996 ‎‡2 PTBNP|1648518‏
996 ‎‡2 RERO|A000014539‏
996 ‎‡2 PTBNP|1331112‏
996 ‎‡2 DNB|1199141321‏
996 ‎‡2 ISNI|0000000059207701‏
996 ‎‡2 PTBNP|1604141‏
996 ‎‡2 SUDOC|087796236‏
996 ‎‡2 RERO|A003425816‏
996 ‎‡2 BNE|XX1223620‏
996 ‎‡2 BLBNB|000445681‏
996 ‎‡2 ISNI|0000000059386375‏
996 ‎‡2 LC|no2021015913‏
996 ‎‡2 LC|n 2023045597‏
996 ‎‡2 ISNI|0000000069412143‏
996 ‎‡2 ISNI|0000000043005857‏
996 ‎‡2 NII|DA14327235‏
996 ‎‡2 ISNI|0000000068183684‏
996 ‎‡2 ISNI|0000000078781338‏
996 ‎‡2 BNF|13484411‏
996 ‎‡2 LC|nr 94011941‏
996 ‎‡2 NUKAT|n 2011051719‏
996 ‎‡2 BNE|XX1028723‏
996 ‎‡2 ISNI|0000000067987138‏
996 ‎‡2 CAOONL|ncf11521469‏
996 ‎‡2 PTBNP|81984‏
996 ‎‡2 DNB|1137894393‏
996 ‎‡2 PTBNP|1842469‏
996 ‎‡2 BNE|XX4759487‏
996 ‎‡2 LC|no 99070212‏
996 ‎‡2 DNB|130596760‏
996 ‎‡2 BNC|981058616893706706‏
996 ‎‡2 LC|n 2024251718‏
996 ‎‡2 PTBNP|1032688‏
996 ‎‡2 BNE|XX836824‏
996 ‎‡2 ISNI|0000000122536162‏
996 ‎‡2 PTBNP|1900106‏
996 ‎‡2 BNE|XX1412464‏
996 ‎‡2 ISNI|0000000060631323‏
996 ‎‡2 BNE|XX1039799‏
996 ‎‡2 BNC|981058516812906706‏
996 ‎‡2 BIBSYS|1459181431773‏
996 ‎‡2 PTBNP|1873329‏
996 ‎‡2 BNE|XX821437‏
996 ‎‡2 ISNI|0000000112469277‏
996 ‎‡2 SUDOC|142670197‏
996 ‎‡2 SUDOC|188740090‏
996 ‎‡2 LC|n 2013076118‏
996 ‎‡2 BLBNB|000385769‏
996 ‎‡2 DNB|1103698540‏
996 ‎‡2 BNC|981058510988006706‏
996 ‎‡2 ISNI|0000000418772818‏
996 ‎‡2 ISNI|0000000001174927‏
996 ‎‡2 LC|n 91012687‏
996 ‎‡2 BLBNB|000276062‏
996 ‎‡2 DNB|1034338064‏
996 ‎‡2 SUDOC|035562730‏
996 ‎‡2 SZ|1151729124‏
996 ‎‡2 LC|nr2007006270‏
996 ‎‡2 BNE|XX4848313‏
996 ‎‡2 BNF|17167305‏
996 ‎‡2 ISNI|0000000079757145‏
996 ‎‡2 SUDOC|11250275X‏
996 ‎‡2 RERO|A003940739‏
996 ‎‡2 BNF|12021138‏
996 ‎‡2 ISNI|0000000373515833‏
996 ‎‡2 ISNI|0000000059204762‏
996 ‎‡2 PTBNP|229972‏
996 ‎‡2 ISNI|0000000060970739‏
996 ‎‡2 BNE|XX885420‏
996 ‎‡2 BNE|XX1021764‏
996 ‎‡2 ISNI|0000000059208421‏
996 ‎‡2 ISNI|0000000068492241‏
996 ‎‡2 BNF|16237693‏
996 ‎‡2 ISNI|0000000068780147‏
996 ‎‡2 ISNI|0000000059300391‏
996 ‎‡2 BNE|XX1774616‏
996 ‎‡2 LC|n 50031112‏
996 ‎‡2 DNB|1056368799‏
996 ‎‡2 SUDOC|071506586‏
996 ‎‡2 ISNI|0000000059266939‏
996 ‎‡2 ISNI|0000000060601263‏
996 ‎‡2 ISNI|0000000107809898‏
996 ‎‡2 BNE|XX1423337‏
996 ‎‡2 BNE|XX5713258‏
996 ‎‡2 DNB|1053076673‏
996 ‎‡2 DNB|139298819‏
996 ‎‡2 ISNI|0000000417304561‏
996 ‎‡2 ISNI|0000000362138948‏
996 ‎‡2 BNF|13754017‏
996 ‎‡2 LC|no2011110781‏
996 ‎‡2 NUKAT|n 2021204279‏
996 ‎‡2 ISNI|0000000060326871‏
996 ‎‡2 LC|n 2022002804‏
996 ‎‡2 PTBNP|223688‏
996 ‎‡2 DNB|1157167543‏
996 ‎‡2 RERO|A003940724‏
996 ‎‡2 BNE|XX4734149‏
996 ‎‡2 RERO|A003940722‏
996 ‎‡2 BNF|14637534‏
996 ‎‡2 ISNI|000000005988047X‏
996 ‎‡2 ISNI|0000000117788824‏
996 ‎‡2 ISNI|0000000118645024‏
996 ‎‡2 BNE|XX954087‏
996 ‎‡2 PTBNP|1230983‏
996 ‎‡2 LC|n 93071768‏
996 ‎‡2 BNC|981058516552706706‏
996 ‎‡2 ISNI|0000000059989125‏
996 ‎‡2 SUDOC|151158118‏
996 ‎‡2 ISNI|000000006039150X‏
996 ‎‡2 ISNI|0000000068102303‏
996 ‎‡2 RERO|A011596577‏
996 ‎‡2 ISNI|0000000052806998‏
996 ‎‡2 BIBSYS|1606126540814‏
996 ‎‡2 ISNI|0000000080161162‏
996 ‎‡2 DNB|130430013‏
996 ‎‡2 NII|DA1445749X‏
996 ‎‡2 PTBNP|1052934‏
996 ‎‡2 LC|n 2016036690‏
996 ‎‡2 LC|n 93098839‏
996 ‎‡2 SUDOC|028360141‏
996 ‎‡2 ISNI|000000006972442X‏
996 ‎‡2 PLWABN|9814189392705606‏
996 ‎‡2 BNF|13753749‏
996 ‎‡2 LC|n 2012074281‏
996 ‎‡2 PTBNP|53997‏
996 ‎‡2 LC|no2009045742‏
996 ‎‡2 BNE|XX969627‏
996 ‎‡2 PTBNP|1093649‏
996 ‎‡2 SUDOC|139283390‏
996 ‎‡2 NTA|189866578‏
996 ‎‡2 BNE|XX1707816‏
996 ‎‡2 RERO|A011306747‏
996 ‎‡2 BNF|14561436‏
996 ‎‡2 PTBNP|1633444‏
996 ‎‡2 SUDOC|066898552‏
996 ‎‡2 PTBNP|185673‏
996 ‎‡2 ISNI|0000000393828431‏
996 ‎‡2 SUDOC|06689879X‏
996 ‎‡2 DNB|1164479245‏
996 ‎‡2 ISNI|0000000123750240‏
996 ‎‡2 ISNI|0000000070635547‏
996 ‎‡2 ISNI|000000006015773X‏
996 ‎‡2 ISNI|0000000066373900‏
996 ‎‡2 SUDOC|097407410‏
996 ‎‡2 BNE|XX927246‏
996 ‎‡2 BNE|XX1316594‏
996 ‎‡2 BNC|981058509102906706‏
996 ‎‡2 BNF|13763518‏
996 ‎‡2 BNE|XX1276628‏
996 ‎‡2 NDL|00942848‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏